SCHEMBL16869986

SCHEMBL16869986

CC(C)c1ccc(NCCO)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
RAB9A P51151 2/20 0.46
HPGD P15428 1/20 0.43
KIF11 P52732 1/20 0.42
EPHX1 P07099 2/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
RORC P51449 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11113503 0.88 ALDH1A1 (0.47) SMN1; SMN2RAB9AHPGDKIF11EPHX1
SCHEMBL2064181 0.87 MAPT (0.54) SMN1; SMN2HPGDKIF11EPHX1MAPT
SCHEMBL11957885 0.83 SMN1; SMN2 (0.46) SMN1; SMN2RAB9AHPGDKIF11EPHX1
SCHEMBL6152657 0.82 MAPT (0.50) RAB9AMAPTGAAKDM4EALDH1A1
SCHEMBL1401829 0.81 GAA (0.38) MAPTGAARORCKDM4EALDH1A1
SCHEMBL12963093 0.81 EPHX1 (0.46) SMN1; SMN2RAB9AHPGDKIF11EPHX1
SCHEMBL11507189 0.79 MAPT (0.55) RAB9AMAPTGAAKDM4EALDH1A1
SCHEMBL20883650 0.79 MAPT (0.46) SMN1; SMN2HPGDKIF11EPHX1MAPT
SCHEMBL21496234 0.79 SMN1; SMN2 (0.38) SMN1; SMN2RAB9AMAPTGAAGRIN2D
SCHEMBL1947590 0.79 NFKB1 (0.43) SMN1; SMN2HPGDKIF11EPHX1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118338879-A Curable composition for dental use 可乐丽则武齿科株式会社 2024-07-12 CN disclosed
CN-112545901-B One-part dental adhesive composition 株式会社松风 2024-03-22 CN disclosed
CN-117597099-A Curable composition for dental use 可乐丽则武齿科株式会社 2024-02-23 CN disclosed
CN-112135598-B Macromer-based photocurable dental impression material 登士柏希罗纳有限公司 2023-12-22 CN disclosed
CN-110317226-B Silane coupling compounds and curable dental compositions containing the same 株式会社松风 2023-12-19 CN disclosed
CN-111683640-B dental composition 登士柏希罗纳有限公司 2023-10-27 CN disclosed
CN-116916872-A Dental composition 可乐丽则武齿科株式会社 2023-10-20 CN disclosed
CN-114929158-B Method for producing denture, curable composition for photoforming, and kit for producing denture 株式会社德山齿科 2023-10-20 CN disclosed
CN-113677293-B Curable composition for dental restoration 可乐丽则武齿科株式会社 2023-10-10 CN disclosed
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS BC INC. (CA) 2023-08-24 US disclosed
CN-111093559-A Dental mill blank and method for producing same 可乐丽则武齿科株式会社 2020-05-01 CN disclosed
CN-111050731-A Non-solvent adhesive composition for dental use 可乐丽则武齿科株式会社 2020-04-21 CN disclosed
WO-2020067146-A1 RADICAL POLYMERIZABLE SILANE COUPLING COMPOUND HAVING URETHANE BOND AND USING DIISOCYANATE AS SUBSTRATE 株式会社松風 2020-04-02 WO disclosed
WO-2020031444-A1 CURABLE COMPOSITION FOR DENTISTRY 株式会社ジーシー 2020-02-13 WO disclosed
CN-110785159-A Dual paste type dental curable composition 可乐丽则武齿科株式会社 2020-02-11 CN disclosed
CN-106456452-B Self-adhesive dental composite resin 可乐丽则武齿科株式会社 2020-01-31 CN disclosed
WO-2019203356-A1 ADHESIVE COMPOSITION FOR DENTAL USE クラレノリタケデンタル株式会社 2019-10-24 WO disclosed
US-20170029490-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS INC. (CA) 2017-02-02 US disclosed
US-20170029490-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS INC. (CA) 2017-02-02 US disclosed
WO-2015095953-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2015-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES MPST, TPST2, SULT1A1 SMN1; SMN2 935/4885RAB9A 2618/4885HPGD 3500/4885
US-20170029490-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES MPST, TPST2, SULT1A1 SMN1; SMN2 935/4885RAB9A 2618/4885HPGD 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.